 |
Corporate News
22-Aug-23
|
|
|
|
|
|
|
|
|
|
|
|
Piramal Pharma allots 12.96 cr equity shares on rights basis
|
|
|
|
|
|
|
|
Piramal Pharma has allotted 12,96,04,598 equity shares at a price of Rs 81 per equity share (including a premium of Rs 71 per equity share) on rights basis. Accordingly, pursuant to the Allotment, the paid-up equity share capital of the company has increased from Rs 1193,31,85,000 to Rs 1322,92,30,980.
|
|
|
|
Previous News |
Piramal Pharma’s Ahmedabad facility gets zero USFDA observations
(
Hot Pursuit
-
15-Jul-24
08:53
)
|
|
|
Piramal Pharma unit appoints Jeffrey Hampton as president, COO
(
Hot Pursuit
-
06-Jun-23
15:14
)
|
|
|
Piramal Pharma arm launches new high-throughput screening facility in Ahmedabad
(
Corporate News
-
16-Oct-23
18:32
)
|
|
|
Piramal Pharma reports consolidated net profit of Rs 10.11 crore in the December 2023 quarter
(
Results
-
Announcements
31-Jan-24
07:43
)
|
|
|
Piramal Pharma allots 12.96 cr equity shares on rights basis
(
Corporate News
-
22-Aug-23
17:55
)
|
|
|
Piramal Pharma rises after USA facility clears USFDA inspection
(
Hot Pursuit
-
18-Apr-24
09:40
)
|
|
|
Piramal Pharma drops on listing
(
Hot Pursuit
-
19-Oct-22
10:46
)
|
|
|
Piramal Pharma appoints Jeffrey Hampton as President & COO for its critical care biz
(
Corporate News
-
06-Jun-23
16:07
)
|
|
|
Piramal Pharma to hold board meeting
(
Corporate News
-
02-Feb-23
14:08
)
|
|
|
Piramal Pharma Q1 net loss narrows to Rs 98 cr
(
Hot Pursuit
-
04-Aug-23
11:18
)
|
|
|
Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility
(
Corporate News
-
30-Sep-24
18:48
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|